Adaptive medium voltage therapy for cardiac arrhythmias
US8483822B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2010 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Jul 2, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/3993
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.